{"id":484460,"date":"2021-04-29T09:04:27","date_gmt":"2021-04-29T13:04:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/"},"modified":"2021-04-29T09:04:27","modified_gmt":"2021-04-29T13:04:27","slug":"sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/","title":{"rendered":"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE, April  29, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G5xgg2NrygSWRAro9G8s9rPqCxLl2Rd0Tg91NEx_zUmU8__eaP90YzgsY8PTERoeNoQ0dgZAyubD748E1rZpA1A4a2mo_DwJXrZFzBlK9Ag=\" rel=\"nofollow noopener\" target=\"_blank\">SEngine Precision Medicine<\/a>, a precision oncology company that pre-tests drugs on live tumor specimens employing its CLIA certified PARIS<sup>\u00ae<\/sup> Test, today announced that new data from a study summarizing the predictive value of the PARIS<sup>\u00ae<\/sup> Test across solid tumor cancers will be presented during a poster session (abstract number 2602) at the American Society of Clinical Oncology annual meeting, to be held virtually June 4-8, 2021.<\/p>\n<p>Details related to the poster presentation are as follows:<br \/>Title: A cancer organogram test as a guide for oncology treatments in solid tumors: an analysis of 628 tests in 419 patients<br \/>First Author: Astrid Margossian, MD, PhD<br \/>Senior Author: Carla Grandori, MD, PhD<br \/>Abstract Number: 2602<br \/>Poster Session: Developmental Therapeutics\u2014 Immunotherapy<\/p>\n<p>\n        <strong>About PARIS<sup>\u00ae<\/sup> Test<\/strong>\u00a0<br \/>The PARIS<sup>\u00ae<\/sup>\u00a0Test is a next generation diagnostic test that predicts drug responses integrating knowledge of cancer genomics with drug sensitivity testing of patient-derived live cells combined with robotics and AI-driven computational tools. SEngine\u2019s CLIA certified PARIS<sup>\u00ae<\/sup> Test generates actionable drug sensitivity reports for patients and is applicable to all solid tumors\u00a0including colon, breast, lung, ovarian and pancreatic cancer. Cancer-derived cells grown\u00a0in 3D outside the body maintain the functionality of the original tumor as well as its genomic characteristics.\u00a0For cancers\u00a0where\u00a0a treatment\u00a0path is not clear, such as\u00a0many metastatic and recurrent cancers,\u00a0the PARIS<sup>\u00ae<\/sup> Test provides crucial information to\u00a0treating physicians\u00a0to\u00a0match the right drug to the right patient.<\/p>\n<p>\n        <strong>About SEngine Precision Medicine<\/strong><br \/>\n        <br \/>SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer therapies by pre-testing drugs on patient-derived 3D cultures utilizing patient specific tumor cells.\u00a0As a spin-out from the world-renowned Fred Hutchinson Cancer Research Center, SEngine is leveraging over two decades of R&amp;D in diagnostics and drug discovery. The Company is commercializing the PARIS<sup>\u00ae<\/sup> Test, a next generation diagnostic test that predicts drug responses integrating knowledge of cancer genomics with phenotypic testing of patient-derived live cells combined with robotics and AI-driven computational tools. SEngine\u2019s CLIA certified PARIS<sup>\u00ae<\/sup> Test generates actionable drug sensitivity reports for patients with solid tumors. SEngine is also pursuing drug discovery via strategic collaborations with biopharmaceutical \/ pharma companies by deploying its precision oncology platform.<\/p>\n<p>Discover more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8yvwcmwsG5Sg6OnUDTCMhxHrERxfPX0i2Fxlm-8mwyF-l5Zlp9xobMwUTka2x-6Jhz8TXVF5n0V-qKK_VeNz1-HUaP-ZJIwERsDSMjNndUw=\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>SengineMedicine.com<\/u><\/strong><\/a>\u00a0and follow the latest news from SEngine on Twitter at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jIq6NdGFPQ8rMP1m2xG5PmW8EnECz0Szp-Qt2gtJdIRDEo2He_0XDxbtvQ6tsnUrDKLeaq_KUwgFO8EikSBn-RO5f5dqef-MiUhwdCs-SDQ=\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>@SEngineMedicine<\/u><\/strong><\/a>\u00a0and on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eG8LV5GRgZQOfwEfod_-hHnhCkkSSPdJbUbxplOdSMyaQNO_eU_fJwqlBhxoFGRkIvT-YTm2dw0CvO6rX41Qz3mB-D1FhNQp_YNaSibExUakCtYtKshQnLY8jm-Ei67Z\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>LinkedIn<\/u><\/strong><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Stephanie Carrington<br \/><strong><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LIeDkBcFlVnvxYCm8SVh0EhYS0zP1h_bBCcPoxEfe4Z4nZB_pzwBRavWULrV_4vOh1x8nik91dstCo5FB1MCWcDJjduaM7HM5LhF4OZvtaiwmntOhJ78xIi2a4ggB2zFvBI5PpdawLELaddeaZ6Geg==\" rel=\"nofollow noopener\" target=\"_blank\">stephanie.carrington@westwicke.com<\/a><\/u><\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9zaO0fJvOz5QhVFiH6P2GvuIqna1oXJnFG7h6lWSr0eTsuHcyVkbep093cdlquLsEnYlaX8GL_GVb5tcaIDtSQdoaokBuByVIXxLM_VXcgF8a_o_AmJr91N4kOgO8Flm4DM9O_8hjnIFKc43Xmm1seLaNoOU48FsCgeHWWNSRIqSD-e0mnbu9Fwg3dCpWcjQuGwQSrQ-sYU3cHxzQURT3WTKE69K4i-8stsdghkwmTL3tlCTUlgXKMxazCIsBQ7zLy3cXyJ4lTgQUgtASIn5EyPFnQzxiw-X-JZu6GOg1OPAeohnZoDxvloCaan26AvsYvC6NYostJPy5n9jyeyKzi31l3M7Vut1AjPoABVt6xl0bsvEKNUQmpthaXVAYVgf\" rel=\"nofollow noopener\" target=\"_blank\"><br \/><\/a>646-277-1282<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6f725a0d-791b-426a-bce4-13fe4594e95c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, April 29, 2021 (GLOBE NEWSWIRE) &#8212; SEngine Precision Medicine, a precision oncology company that pre-tests drugs on live tumor specimens employing its CLIA certified PARIS\u00ae Test, today announced that new data from a study summarizing the predictive value of the PARIS\u00ae Test across solid tumor cancers will be presented during a poster session (abstract number 2602) at the American Society of Clinical Oncology annual meeting, to be held virtually June 4-8, 2021. Details related to the poster presentation are as follows:Title: A cancer organogram test as a guide for oncology treatments in solid tumors: an analysis of 628 tests in 419 patientsFirst Author: Astrid Margossian, MD, PhDSenior Author: Carla Grandori, MD, PhDAbstract Number: 2602Poster Session: Developmental Therapeutics\u2014 Immunotherapy About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484460","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, April 29, 2021 (GLOBE NEWSWIRE) &#8212; SEngine Precision Medicine, a precision oncology company that pre-tests drugs on live tumor specimens employing its CLIA certified PARIS\u00ae Test, today announced that new data from a study summarizing the predictive value of the PARIS\u00ae Test across solid tumor cancers will be presented during a poster session (abstract number 2602) at the American Society of Clinical Oncology annual meeting, to be held virtually June 4-8, 2021. Details related to the poster presentation are as follows:Title: A cancer organogram test as a guide for oncology treatments in solid tumors: an analysis of 628 tests in 419 patientsFirst Author: Astrid Margossian, MD, PhDSenior Author: Carla Grandori, MD, PhDAbstract Number: 2602Poster Session: Developmental Therapeutics\u2014 Immunotherapy About &hellip; Continue reading &quot;SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T13:04:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting\",\"datePublished\":\"2021-04-29T13:04:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/\"},\"wordCount\":403,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/\",\"name\":\"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=\",\"datePublished\":\"2021-04-29T13:04:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting - Market Newsdesk","og_description":"SEATTLE, April 29, 2021 (GLOBE NEWSWIRE) &#8212; SEngine Precision Medicine, a precision oncology company that pre-tests drugs on live tumor specimens employing its CLIA certified PARIS\u00ae Test, today announced that new data from a study summarizing the predictive value of the PARIS\u00ae Test across solid tumor cancers will be presented during a poster session (abstract number 2602) at the American Society of Clinical Oncology annual meeting, to be held virtually June 4-8, 2021. Details related to the poster presentation are as follows:Title: A cancer organogram test as a guide for oncology treatments in solid tumors: an analysis of 628 tests in 419 patientsFirst Author: Astrid Margossian, MD, PhDSenior Author: Carla Grandori, MD, PhDAbstract Number: 2602Poster Session: Developmental Therapeutics\u2014 Immunotherapy About &hellip; Continue reading \"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T13:04:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting","datePublished":"2021-04-29T13:04:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/"},"wordCount":403,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/","name":"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=","datePublished":"2021-04-29T13:04:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNjE3OCM0MTQ1NjczIzIxOTc1MjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sengine-precision-medicine-to-present-pan-cancer-data-on-predictive-value-of-paris-test-at-2021-asco-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SEngine Precision Medicine to Present Pan Cancer Data on Predictive Value of PARIS\u00ae Test at 2021 ASCO Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484460"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484460\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}